Headline
The latest stories from AHA Today.
In part three of a Value Rounds series on working toward value together, leaders from Northwell Health and Atrium Health's Carolinas Medical Center discuss the role of health care providers — from the front lines to leadership — in improving outcomes, enhancing the patient experience and reducing…
The Food and Drug Administration Oct. 14 approved Inmazeb for treating Zaire ebolavirus infection in adult and pediatric patients.
The American Medical Association’s annual review of U.S. health insurance markets indicates an erosion of competition and choice for many patients, particularly in markets where it is most scarce.
Medicaid enrollment for fiscal year 2021 is expected to jump 8.2%, with state spending to accelerate by 8.4%, according to data from 42 state Medicaid directors and compiled by the Kaiser Family Foundation.
The Federal Reserve will host a webinar Oct. 21 at 2 p.m. ET to help borrowers learn about the Main Street Lending Program and provide an opportunity for borrowers to get answers to specific questions on the program and its operations. Questions are to be submitted in advance to questions@askthefed…
The Centers for Medicare & Medicaid Services announced that it has expanded the list of telehealth services that Medicare will pay for during the COVID-19 public health emergency.
Hospital and health system trustees are promoting value in their communities by tackling societal factors that influence the health and well-being of residents.
The AHA, the American Medical Association and American Nurses Association urged President Trump to rescind Executive Order 13950, Combating Race and Sex Stereotyping, arguing that failing to do so “would effectively reverse decades of progress in combating racial inequality.”
The Department of Health and Human Services and the Department of Defense awarded $481 million to Cue Health Inc. to expand production of a point-of-care COVID-19 molecular test with capabilities to produce results in 20 minutes.
The National Institutes of Health Oct. 13 announced a study designed to identify promising COVID-19 therapies and investigational drugs that merit larger clinical trials.